04/18/2024
3:30 PM | MyMD Pharmaceuticals, Inc. (Filer)
MyMD Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/08/2024
3:49 PM | MyMD Pharmaceuticals, Inc. (Filer)
MyMD Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/01/2024
4:29 PM | MyMD Pharmaceuticals, Inc. (Filer)
MyMD Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/26/2024
3:30 PM | MyMD Pharmaceuticals, Inc. (Filer)
MyMD Pharmaceuticals (Filer)
| Form 8-K/A | |
03/07/2024
3:30 PM | MyMD Pharmaceuticals, Inc. (Filer)
MyMD Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/05/2024
10:00 AM | MyMD Pharmaceuticals, Inc. (Filer)
MyMD Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2024
2:13 PM | Global X Management CO LLC (Filed by)
MyMD Pharmaceuticals, Inc. (Subject)
MyMD Pharmaceuticals (Subject)
| Form SC 13G | |
|
02/14/2024
10:27 AM | Iroquois Capital Management, LLC (Filed by)
MyMD Pharmaceuticals, Inc. (Subject)
MyMD Pharmaceuticals (Subject)
| Form SC 13G/A | |
12/06/2023
8:15 AM | MyMD Pharmaceuticals, Inc. (Filer)
MyMD Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/19/2023
8:00 AM | MyMD Pharmaceuticals, Inc. (Filer)
MyMD Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/13/2023
4:00 PM | MyMD Pharmaceuticals, Inc. (Filer)
MyMD Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/04/2023
3:30 PM | MyMD Pharmaceuticals, Inc. (Filer)
MyMD Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/08/2023
4:24 PM | MyMD Pharmaceuticals, Inc. (Filer)
MyMD Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/24/2023
4:58 PM | MyMD Pharmaceuticals, Inc. (Issuer)
MyMD Pharmaceuticals (Issuer)
Rivard Paul (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/18/2023
3:21 PM | MyMD Pharmaceuticals, Inc. (Issuer)
MyMD Pharmaceuticals (Issuer)
Rivard Paul (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/14/2023
7:30 AM | MyMD Pharmaceuticals, Inc. (Filer)
MyMD Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/01/2023
3:30 PM | MyMD Pharmaceuticals, Inc. (Filer)
MyMD Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/31/2023
8:00 AM | MyMD Pharmaceuticals, Inc. (Filer)
MyMD Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/21/2023
3:30 PM | MyMD Pharmaceuticals, Inc. (Filer)
MyMD Pharmaceuticals (Filer)
| Form DEFA14A | |
07/14/2023
7:30 AM | MyMD Pharmaceuticals, Inc. (Filer)
MyMD Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/30/2023
3:30 PM | MyMD Pharmaceuticals, Inc. (Filer)
MyMD Pharmaceuticals (Filer)
| Form DEF 14A | |
06/30/2023
3:30 PM | MyMD Pharmaceuticals, Inc. (Filer)
MyMD Pharmaceuticals (Filer)
| Form ARS | |
06/09/2023
5:00 PM | MyMD Pharmaceuticals, Inc. (Issuer)
MyMD Pharmaceuticals (Issuer)
White Billy Joe (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2023
5:00 PM | MyMD Pharmaceuticals, Inc. (Issuer)
MyMD Pharmaceuticals (Issuer)
Rivard Paul (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2023
5:00 PM | MyMD Pharmaceuticals, Inc. (Issuer)
MyMD Pharmaceuticals (Issuer)
Silverman Joshua (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2023
5:00 PM | EAGLE CRAIG (Reporting)
MyMD Pharmaceuticals, Inc. (Issuer)
MyMD Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2023
5:00 PM | MyMD Pharmaceuticals, Inc. (Issuer)
MyMD Pharmaceuticals (Issuer)
Schreiber Christopher C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2023
5:00 PM | MyMD Pharmaceuticals, Inc. (Issuer)
MyMD Pharmaceuticals (Issuer)
Uzonwanne Jude (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2023
5:00 PM | Kaplin Adam (Reporting)
MyMD Pharmaceuticals, Inc. (Issuer)
MyMD Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2023
5:00 PM | Chapman Christopher C JR (Reporting)
MyMD Pharmaceuticals, Inc. (Issuer)
MyMD Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
